Home > Income Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Consolidated Net Profit

    Back to Income Statement
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹15 Cr₹10 Cr₹7.37 Cr₹3.67 Cr₹0.84 Cr

What is the latest Consolidated Net Profit of KILITCH DRUGS (INDIA) ?

The latest Consolidated Net Profit ratio of KILITCH DRUGS (INDIA) is ₹15 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹15 Cr
Mar2023₹10 Cr
Mar2022₹7.37 Cr
Mar2021₹3.67 Cr
Mar2020₹0.84 Cr

How is Consolidated Net Profit of KILITCH DRUGS (INDIA) Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹15 Cr
39.75
Mar2023 ₹10 Cr
41.82
Mar2022 ₹7.37 Cr
100.68
Mar2021 ₹3.67 Cr
335.99
Mar2020 ₹0.84 Cr -

Compare Consolidated Net Profit of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹549.3 Cr -5.2% -4.1% -1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,725.0 Cr 2.5% 0.2% 17.2% Stock Analytics
DIVIS LABORATORIES ₹159,525.0 Cr 2.1% 3.7% 66.4% Stock Analytics
CIPLA ₹123,206.0 Cr 0.9% 0.1% 14.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,519.0 Cr -0.6% 0.4% 28.3% Stock Analytics
DR REDDYS LABORATORIES ₹97,927.5 Cr -0.3% -2.2% -0.1% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

-5.2%

-4.1%

-1%

SENSEX

0.8%

3.8%

8.4%


You may also like the below Video Courses